![Teva Canada Announces the Launch of a Generic Version of (PR)Abilify®, (PR) Teva-Aripiprazole Tablets for the treatment of Schizophrenia Teva Canada Announces the Launch of a Generic Version of (PR)Abilify®, (PR) Teva-Aripiprazole Tablets for the treatment of Schizophrenia](https://mma.prnewswire.com/media/740717/Teva_Canada_Limited_Teva_Canada_Announces_the_Launch_of_a_Generi.jpg)
Teva Canada Announces the Launch of a Generic Version of (PR)Abilify®, (PR) Teva-Aripiprazole Tablets for the treatment of Schizophrenia
Sp. zn. sukls142598/2020 Příbalová informace: informace pro uživatele Aripiprazole Teva 10 mg tablety Aripiprazole Teva 15 m
![Teva Canada Announces the Launch of a Generic Version of (PR)Abilify®, (PR) Teva-Aripiprazole Tablets for the treatment of Schizophrenia Teva Canada Announces the Launch of a Generic Version of (PR)Abilify®, (PR) Teva-Aripiprazole Tablets for the treatment of Schizophrenia](https://mma.prnewswire.com/media/740720/Teva_Canada_Limited_Teva_Canada_Announces_the_Launch_of_a_Generi.jpg?p=facebook)